This organization files Form 990, which has no section for application policy. Its filings cannot say either way.
The latest filing we hold carries no statement about applications. That is not the same as closed: public-charity Form 990s have no field for it, and many foundations leave the section blank.
No parsed e-filed return is on record for this organization yet, so year-by-year financials are not available.
Asset, income and revenue figures come from the IRS master file (the IRS Exempt Organizations Business Master File), a coarse annual extract. Year-by-year figures appear once the organization's e-filed returns are in the database.
Recipient focus areas
Where recipients are
Based on the 100% of grant rows we could match to an organization record. The rest stay as reported. The IRS assigns the NTEE category when it grants exemption. It often reflects the original filing, not today's giving.
| Recipient | Purpose | Amount | Year | Source |
|---|---|---|---|---|
| THOMAS JEFFERSON UNIVERSITYPHILADELPHIA, PA | FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | $39,782 | 2022 |
Recipients are shown as the funder wrote them on the return. A recipient with a link was matched to an organization record; the rest stay as reported and are never guessed.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Michael Cygan | DIRECTOR | 5.00 | $0 |
| Anthony Cygan | VICE PRESIDENT | 3.00 | $0 |
| David Cygan | SECRETARY | 5.00 | $0 |
| Jane Cygan | TREASURER | 10.00 | $0 |
| Stephen Cygan | PRESIDENT | 3.00 | $0 |
| Nathan Cygan | DIRECTOR | 3.00 | $0 |
| Gregory Cygan | DIRECTOR | 4.00 | $0 |
| Marlene Mayza | DIRECTOR | 3.00 | $0 |
| Celeste Vaughn | DIRECTOR | 8.00 | $0 |
| Laura Depenbusch | DIRECTOR | 8.00 | $0 |
From the officer list on the latest e-filed return. Compensation is as reported there; a blank means the return carries no figure.
| THOMAS JEFFERSON UNIVERSITYPHILADELPHIA, PA | FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | $36,500 | 2021 |
| THOMAS JEFFERSON UNIVERSITYPHILADELPHIA, PA | FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | $36,000 | 2023 |
| THOMAS JEFFERSON UNIVERSITYPHILADELPHIA, PA | $30,000 IN FUNDING WAS PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. $2,000 IN FUNDING WAS USED FOR JEFFERSON'S "COMPASSIONATE CARE" INITIATIVES. | $32,000 | 2024 |
| FOX CHASE INSTITUTE FOR CANCER RESEARCHPHILADELPHIA, PA | FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | $30,000 | 2023 |
| THOMAS JEFFERSON UNIVERSITYPHILADELPHIA, PA | FUNDING PROVIDED TO THE PANCREAS, BILIARY, & RELATED CANCER CENTER AT SIDNEY KIMMEL CANCER CENTER AT JEFFERSON UNIVERSITY, AN NCI-DESIGNATED FACILITY. FUNDING SUPPORTS RESEARCH TO IMPROVE EARLY DETECTION OF PANCREATIC CANCER AND DEVELOP MORE EFFECTIVE SCREENING PROCEDURES. THIS FACILITY IS LEADING INVESTIGATIONS INTO GENETIC, ENVIRONMENTAL, AND LIFESTYLE LINKS TO PANCREATIC AND RELATED CANCERS, INCLUDING NOVEL APPROACHES TO INDIVIDUALIZED THERAPY BASED ON MOLECULAR GENETIC FEATURES OF TUMORS. | $29,000 | 2020 |
| FOX CHASE INSTITUTE FOR CANCER RESEARCHPHILADELPHIA, PA | FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | $28,500 | 2021 |
| FOX CHASE INSTITUTE FOR CANCER RESEARCHPHILADELPHIA, PA | FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | $27,000 | 2024 |
| FOX CHASE INSTITUTE FOR CANCER RESEARCHPHILADELPHIA, PA | FUNDING WAS PROVIDED TO FOX CHASE INSTITUTE FOR CANCER RESEARCH TO ADVANCE RESEARCH BEING CONDUCTED BY THE CUIKERMAN LAB/MARVIN & CONCETTA GREENBURG PANCREATIC CANCER INSTITUTE | $20,000 | 2022 |
| ST LUKE'S HOSPITAL OF BETHLEHEMBETHLEHEM, PA | FUNDING WAS PROVIDED TO ST. LUKE'S CANCER CENTER FOR "COMPASSIONATE CARE" DISTRIBUTION TO FINANCIALLY COMPROMISED PANCREATIC CANCER PATIENTS TO COVER COSTS SUCH AS TRANSPORTATION, UTILITIES, ETC. | $5,000 | 2021 |
| ST LUKE'S HOSPITAL OF BETHLEHEMBETHLEHEM, PA | FUNDING WAS PROVIDED TO ST. LUKE'S CANCER CENTER FOR "COMPASSIONATE CARE" DISTRIBUTION TO FINANCIALLY COMPROMISED PANCREATIC CANCER PATIENTS TO COVER COSTS SUCH AS TRANSPORTATION, UTILITIES, ETC. | $4,000 | 2020 |
Form 990 · FY2023 · period ending Sep 30, 2023IRS bulk XML
Filing id 202432269349301058
Form 990 · FY2022 · period ending Sep 30, 2022
Filing id 202322279349300407
Form 990 · FY2021 · period ending Sep 30, 2021
Filing id 202212279349301416
Form 990 · FY2020 · period ending Sep 30, 2020
Filing id 202102239349301985
Form 990 · FY2019 · period ending Sep 30, 2019
Filing id 202012269349300311
Form 990 · FY2018 · period ending Sep 30, 2018
Filing id 201912249349300901
Form 990 · FY2017 · period ending Sep 30, 2017
Filing id 201812259349300641
IRS filings are the source for every fact on this page. Nothing a model writes is ever a source; it can only point at a row here.